Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
References: DSIP
FOXO4-DRI targets the specific FOXO4-p53 anti-apoptotic interaction in senescent cells
AOD 9604 is generally not recommended for individuals with certain health issues like diabetes or heart disease
While BPC 157 has demonstrated great potential in treating many medical conditions, its important to note that more research still needs to be done before it can be considered an approved treatment option
Tolerability: Similar class effects (nausea early on), but cagrilintides long half-life supports steadier exposure and simpler adherence
US$ 21.65
US$ 27.35
US$ 23.82
US$ 24.35
US$ 20.48
US$ 26.83
